comparemela.com

Page 4 - Profoundbio Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genmab Buys ProfoundBio for $1 8B to Boost Oncology Portfolio

Danish drugmaker Genmab said Wednesday it plans to acquire U.S. biotech firm ProfoundBio for $1.8 billion in cash to expand its cancer treatment portfolio.

ADC oncology acquisition to address solid tumours

ADC oncology acquisition to address solid tumours
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Genmab targets new cancer therapies with $1 8 billion ProfoundBio deal

Danish drugmaker Genmab A/S agreed to buy closely held US biotech firm ProfoundBio Inc. for $1.8 billion in cash.

Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio

Company AnnouncementGenmab to acquire ProfoundBio for USD 1.8 billion in cash Acquisition will give Genmab worldwide rights to three candidates in clinical development, including rinatabart sesutecan (Rina-S), plus ProfoundBio’s novel antibody-drug conjugate (ADC) technology platforms Rina-S is a novel, next-g.

Form 10-K Vincerx Pharma, Inc For: Dec 31

Form 10-K Vincerx Pharma, Inc For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.